α-type-1 polarized dendritic cell-based vaccination in recurrent high-grade glioma: a phase I clinical trial
<p>Abstract</p> <p>Background</p> <p>High-grade gliomas including glioblastoma multiforme (GBM) are among the most malignant and aggressive of tumors, and have a very poor prognosis despite a temozolomide-based intensive treatment. Therefore, a novel therapeutic approac...
Main Authors: | Akiyama Yasuto, Oshita Chie, Kume Akiko, Iizuka Akira, Miyata Haruo, Komiyama Masaru, Ashizawa Tadashi, Yagoto Mika, Abe Yoshiaki, Mitsuya Koichi, Watanabe Reiko, Sugino Takashi, Yamaguchi Ken, Nakasu Yoko |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2012-12-01
|
Series: | BMC Cancer |
Subjects: | |
Online Access: | http://www.biomedcentral.com/1471-2407/12/623 |
Similar Items
-
The Prognostic Significance of Selected HLA Alleles on Prostate Cancer Outcome
by: Savvas Stokidis, et al.
Published: (2023-09-01) -
Association of HLA-A*11:01, -A*24:02, and -B*18:01 with Prostate Cancer Risk: A Case-Control Study
by: Maria Antonietta Manca, et al.
Published: (2023-10-01) -
HLA Class I Allele Expression and Clinical Outcome in De Novo Metastatic Prostate Cancer
by: Savvas Stokidis, et al.
Published: (2020-06-01) -
Can Glycosylation Mask the Detection of MHC Expressing p53 Peptides by T Cell Receptors?
by: Thanh Binh Nguyen, et al.
Published: (2021-07-01) -
Diversity in the HLA-I Recognition of HLA-F Monoclonal Antibodies: HLA-F or HLA-Ib Monospecific, HLA-E or HLA-G Bispecific Antibodies with or without HLA-Ia Reactivity
by: Mepur H. Ravindranath, et al.
Published: (2024-01-01)